AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Worldwide Gene Expression Analysis Industry to 2025 - North America is Found Dominating the Market - ResearchAndMarkets.com

December 17, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Dec 17, 2020--

The “Gene Expression Analysis Market - Growth, Trends, and Forecasts (2020 - 2025)” report has been added to ResearchAndMarkets.com’s offering.

The global gene expression analysis market is found increasing due to the various factors such as increasing government funding towards genomics, growing adoption of personalized medicine and the rapid technological advancements.

ADVERTISEMENT

Personalized medicine is becoming more popular with the growing number of genetic disorders and also with the increasing awareness about personalized medicine is driving the market with a high growth rate in the future.

Companies Mentioned

  • QIAGEN
  • Quest Diagnostics Incorporated
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Novogene Corporation
  • PerkinElmer Inc.
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies
  • Promega Corporation
  • Luminex Corporation

Key Market Trends

Next Generation Sequencing (NGS) is Expected to Grow With a Healthy CAGR

The Next Generation Sequencing (NGS) is a technology in which millions of DNA strands can be sequenced through massive parallelization; this technique is also known as high throughput sequencing. The low cost, high accuracy and speed, and precise results even from low sample input are the main advantages NGS offers over Sanger’s sequencing method.

The NGS is therefore, being used to execute various applications, such as biomarker discovery, oncology studies, personalized medicine, and agricultural and animal research, among others. After the introduction of NGS technologies, in they have had an incredible influence on genomic research.

Next-generation sequencing, currently, has its application in the diagnosis of a variety of illnesses, such as cancer, hematological disorders, neurology, psychiatry, dysmorphology, vision and hearing impairment, cardiology, and pharmacogenomics. It is also used as a tool for noninvasive prenatal tests. Hence they can be used for large-scale screening of SNPs, to ultimately determine if a drug candidate will be effective and safe. The NGS can help change DNA sequencing and genetic characterization used in drug discovery and drug development.

ADVERTISEMENT

North America is Found Dominating the Global Gene Expression Analysis Market

North America dominates the global gene expression analysis market and is expected to maintain its dominance over the forecast period. This growth can be attributed to rising investment and increasing R&D activities towards development of gene therapy, especially in the US. In addition, factors such as the development of gene therapy, focus on gene expression studies, government initiatives, and the availability of funding for NGS research are driving the growth of the gene expression analysis market in North America.

Key Topics Covered:

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Rapid Technological Advancement

4.2.2 Increased Government Funding towards Genomics

4.2.3 Growing Adoption of Personalized Medicine

4.3 Market Restraints

4.3.1 Lack of Skilled Labor

4.3.2 High Cost of the Instruments

4.4 Porter’s Five Force Analysis

5 MARKET SEGMENTATION

5.1 By Technology

5.1.1 Polymerase Chain Reaction (PCR)

5.1.2 Next Generation Sequencing (NGS)

5.1.3 Microarrays

5.1.4 Others

5.2 By Product Type

5.2.1 Instruments

5.2.2 Reagents and Consumables

5.2.3 Services

5.3 By End-user

5.3.1 Drug Discovery

5.3.2 Diagnostic Laboratories

5.3.3 Academic Research Centers

5.4 Geography

5.4.1 North America

5.4.1.1 United States

5.4.1.2 Canada

5.4.1.3 Mexico

5.4.2 Europe

5.4.2.1 Germany

5.4.2.2 United Kingdom

5.4.2.3 France

5.4.2.4 Italy

5.4.2.5 Spain

5.4.2.6 Rest of Europe

5.4.3 Asia-Pacific

5.4.3.1 China

5.4.3.2 Japan

5.4.3.3 India

5.4.3.4 Australia

5.4.3.5 South Korea

5.4.3.6 Rest of Asia-Pacific

5.4.4 Middle-East and Africa

5.4.4.1 GCC

5.4.4.2 South Africa

5.4.4.3 Rest of Middle-East and Africa

5.4.5 South America

5.4.5.1 Brazil

5.4.5.2 Argentina

5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 QIAGEN

6.1.2 Quest Diagnostics Incorporated

6.1.3 F. Hoffmann-La Roche Ltd

6.1.4 Illumina, Inc.

6.1.5 Novogene Corporation

6.1.6 PerkinElmer Inc.

6.1.7 Bio-Rad Laboratories

6.1.8 Thermo Fisher Scientific, Inc.

6.1.9 Agilent Technologies

6.1.10 Promega Corporation

6.1.11 Luminex Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/liaxm7

View source version on businesswire.com:https://www.businesswire.com/news/home/20201217005589/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: GENETICS HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 12/17/2020 07:58 AM/DISC: 12/17/2020 07:58 AM

http://www.businesswire.com/news/home/20201217005589/en